References
- Blix S. The stability of fibrinolytic inhibitors in human scrum and the inhibitor content in animal sera. Scand. J. clin. Lab. Invest 1964; 16: 614
- Hagan J. J., Ablondi F. B., De Renzo E. C. Purification and biochemical properties of human plasminogen. J. biol. Chem 1960; 235: 1005
- Lauritsen O. S. Observations on the inhibition of preparations of porcine plasmin by serum and by urinary trypsin inhibitor (mingin). Scand. J. clin. Lab. Invest 1965; 17: 410
- Andersen H. Some observations on the caseinolytic properties of a purified, activator-free, porcine plasmin preparation. Arch. intern. Med 1966; 18: 64
- Maki M., Kikuchi T. Correlation of antiplas-rain to antitrypsin and antichymotrypsin in human plasma. Tohoku J. exp. Med 1963; 81: 187
- Andersen H., Saito H., Yoneya T. Method of antiplas-min assay in human plasma. Arch. intern. Med 1964; 83: 168
- Norman P. S. Studies on the plasmin system II Inhibition of plasmin by serum or plasma. J. exp. Med 1958; 108: 53
- Ratnoff O. D., Lepow I. H., Pillemer L. The multiplicity of plasmin inhibitors in human serum, demonstrated by the effect of primary amino compounds. Bull. Johns Hopk. Hosp 1954; 94: 169
- Shamash Y., Rimon A. The plasmin inhibitors of plasma I. A method for their estimation. Thrombos. Diathes. haemorrh 1964; 12: 119